1. 548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19. (31st December 2020) Authors: Castagna, Antonella; Hui, David Shu Cheong; Mullane, Kathleen M; Mullane, Kathleen M; Jain, Mamta; Galli, Massimo; Chang, Shan-Chwen; Hyland, Robert H; SenGupta, Devi; Cao, Huyen; Huang, Hailin; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; Lübbert, Christoph; Lye, David Chien Boon; Lye, ... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients. (31st December 2020) Authors: Arribas, Jose Ramon; Arribas, Jose Ramon; Sanyal, Arun J; Soriano, Alex; Chin, Bum Sik; Chin, Bum Sik; Kalimuddin, Shirin; Schreiber, Stefan; Elboudwarej, Emon; Tian, Yuan; Hyland, Robert H; SenGupta, Devi; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; Lübbert, Christoph; Lye, David Chien... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19. (31st December 2020) Authors: Criner, Gerard J; Criner, Gerard J; Ahn, Mi Young; Huhn, Gregory; Subramanian, Aruna; Lumbreras, Carlos; Schmiedel, Stefan; Hyland, Robert H; Suri, Vithika; Cao, Huyen; Wang, Hongyuan; SenGupta, Devi; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; Chen, Yao-Shen; Chen, Yao-Shen; Günthard, ... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 72. Remdesivir vs Standard Care in Patients with Moderate covid-19. (31st December 2020) Authors: Marty, Francisco M; Malhotra, Prashant; Gottlieb, Robert L; Tashima, Karen T; Galli, Massimo; Chai, Louis Yi Ann; SenGupta, Devi; Hyland, Robert H; Wang, Hongyuan; Zhong, Lijie; Cao, Huyen; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; Brown, Michael; Goikoetxea, Ane Josune; Jain, Mamta; ... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir. (31st December 2020) Authors: Diaz, George; Arribas, Jose Ramon; Arribas, Jose Ramon; Robinson, Philip A; Cattelan, Anna Maria; Tashima, Karen T; Tsang, Owen Tak-Yin; Tsang, Owen Tak-Yin; Chen, Yao-Shen; Chen, Yao-Shen; SenGupta, Devi; Vendrame, Elena; Blair, Christiana; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; C... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Issue 10107 (4th November 2017) Authors: Sax, Paul E; Pozniak, Anton; Montes, M Luisa; Koenig, Ellen; DeJesus, Edwin; Stellbrink, Hans-Jürgen; Antinori, Andrea; Workowski, Kimberly; Slim, Jihad; Reynes, Jacques; Garner, Will; Custodio, Joseph; White, Kirsten; SenGupta, Devi; Cheng, Andrew; Quirk, Erin Journal: Lancet Issue: Volume 390:Issue 10107(2017) Page Start: 2073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multi-stakeholder consensus on a target product profile for an HIV cure. Issue 1 (January 2021) Authors: Lewin, Sharon R; Attoye, Timothy; Bansbach, Cathy; Doehle, Brian; Dubé, Karine; Dybul, Mark; SenGupta, Devi; Jiang, Adam; Johnston, Rowena; Lamplough, Rosanne; McCune, Joseph M; Nabel, Gary J; Ndung'u, Thumbi; Pottage, John; Ripin, David; Rooney, James F; Sikazwe, Izukanji; Nsubuga, Moses; Warren... Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial. Issue 1 (January 2019) Authors: Eron, Joseph J; Lelievre, Jean-Daniel; Kalayjian, Robert; Slim, Jihad; Wurapa, Anson K; Stephens, Jeffrey L; McDonald, Cheryl; Cua, Eric; Wilkin, Aimee; Schmied, Brigitte; McKellar, Mehri; Cox, Stephanie; Majeed, Sophia R; Jiang, Shuping; Cheng, Andrew; Das, Moupali; SenGupta, Devi Journal: Lancet Issue: Volume 6:Issue 1(2019) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial. Issue 12 (December 2016) Authors: Gaur, Aditya H; Kizito, Hilda; Prasitsueubsai, Wasana; Rakhmanina, Natella; Rassool, Mohammed; Chakraborty, Rana; Batra, Jagmohan; Kosalaraksa, Pope; Luesomboon, Wicharn; Porter, Danielle; Shao, Yongwu; Myers, Michael; Ting, Lillian; SenGupta, Devi; Quirk, Erin; Rhee, Martin S Journal: Lancet Issue: Volume 3:Issue 12(2016) Page Start: e561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017) Authors: DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Martorell, Claudia T; de Wet, Joseph; Stellbrink, Hans-Jürgen; Molina, Jean-Michel; Post, Frank A; Valero, Ignacio Pérez; Porter, Danielle; Liu, YaPei; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao,... Journal: Lancet Issue: Volume 4:Issue 5(2017) Page Start: e205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗